ATE12779T1 - Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen. - Google Patents

Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.

Info

Publication number
ATE12779T1
ATE12779T1 AT81107365T AT81107365T ATE12779T1 AT E12779 T1 ATE12779 T1 AT E12779T1 AT 81107365 T AT81107365 T AT 81107365T AT 81107365 T AT81107365 T AT 81107365T AT E12779 T1 ATE12779 T1 AT E12779T1
Authority
AT
Austria
Prior art keywords
complex
antithroman
processes
preparation
mixtures containing
Prior art date
Application number
AT81107365T
Other languages
German (de)
English (en)
Inventor
Robert E Jordan
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE12779T1 publication Critical patent/ATE12779T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT81107365T 1980-09-30 1981-09-17 Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen. ATE12779T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19217080A 1980-09-30 1980-09-30
EP81107365A EP0048898B1 (en) 1980-09-30 1981-09-17 Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex

Publications (1)

Publication Number Publication Date
ATE12779T1 true ATE12779T1 (de) 1985-05-15

Family

ID=22708546

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81107365T ATE12779T1 (de) 1980-09-30 1981-09-17 Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.

Country Status (7)

Country Link
EP (1) EP0048898B1 (enExample)
JP (1) JPS5788125A (enExample)
AT (1) ATE12779T1 (enExample)
AU (1) AU553260B2 (enExample)
CA (1) CA1187074A (enExample)
DE (1) DE3170001D1 (enExample)
ES (1) ES8302460A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE98814T1 (de) * 1982-06-10 1984-06-20 Kabivitrum Ab, 11287 Stockholm Antithrombin-heparin komplex.
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
EP0209924A1 (en) * 1985-07-12 1987-01-28 Akzo N.V. New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions
DK148890D0 (da) * 1990-06-19 1990-06-19 Novo Nordisk As Farmaceutisk praeparat
HUT68856A (en) * 1991-01-11 1995-08-28 Glaxo Lab Sa Acridine derivatives, pharmaceutical compositions comprising the same compouds as effective substances and a process for producing the compounds and the pharmaceutical compositions
AT405905B (de) * 1997-03-25 1999-12-27 Immuno Ag Neue verwendung von antithrombin iii
DE60223340T2 (de) * 2001-01-26 2008-08-28 The General Hospital Corp., Boston Serpin-arzneistoffe zur behandlung einer hiv-infektion und verfahren zu deren verwendung
FR2889078B1 (fr) * 2005-07-27 2007-11-02 Aventis Pharma Sa Nouvelle methode de chromatographie d'affinite d'antithrombine iii

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6040859B2 (ja) * 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法

Also Published As

Publication number Publication date
EP0048898B1 (en) 1985-04-17
CA1187074A (en) 1985-05-14
ES505911A0 (es) 1982-12-01
JPH0153650B2 (enExample) 1989-11-15
DE3170001D1 (en) 1985-05-23
AU553260B2 (en) 1986-07-10
AU7578581A (en) 1982-04-08
EP0048898A3 (en) 1982-09-15
ES8302460A1 (es) 1982-12-01
EP0048898A2 (en) 1982-04-07
JPS5788125A (en) 1982-06-01

Similar Documents

Publication Publication Date Title
DE69023073D1 (de) Herstellung von Vorrichtungen mittels lithographischer Prozesse.
DE68923727D1 (de) Verfahren zur Herstellung eines aktiven Matrixsubstrats.
ATE14525T1 (de) Trockene, sterile, gamma-globulin angebundene saeule und verfahren zur herstellung derselben.
DE3689943D1 (de) Degradierte Spezies eines Gewebeplasminogenaktivators, pharmazeutische Zubereitung und Verfahren zur Herstellung derselben.
PT89534A (pt) Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina
DE3650404D1 (de) Verfahren zur Herstellung eines Mittels zur Blutstillung.
ATE12779T1 (de) Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.
ATE4707T1 (de) Pyridyl- und imidazopyridyloxypropanolamine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen sie enthaltend.
ATE141929T1 (de) Verfahren zur herstellung von epoxy-hepariden; die so hergestellten produkte und diese enthaltende pharmazeutische zusammensetzungen
DE3675197D1 (de) Pyridinylpyrimidin-derivate, verfahren zu deren herstellung und diese als wirksamen stoff enthaltende pflanzenkrankheiten-schutzmittel.
NL191172C (nl) Farmaceutisch mengsel dat 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol bevat in combinatie met een bronchiën-verwijdend middel, alsmede farmaceutisch preparaat voor de behandeling van allergische longaandoeningen.
ATA260590A (de) Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DK0391185T3 (da) 1,8-Naphthyridiner
ATE10094T1 (de) 3,4-bis-substituierte 1,2,5-oxadiazol-2-oxide, verfahren zu ihrer herstellung, und sie enthaltende pharmazeutische zubereitungen.
DE3851306D1 (de) Verfahren zur Herstellung von optisch-aktiven 1,2-Diolen.
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DE3770551D1 (de) Verfahren zur herstellung eines pulvers mit grosser wundheilungsfaehigkeit aus der rinde des baumes namens "mimosa tenuiflora poir".
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE4806T1 (de) Isoxazolderivat, dessen herstellung und pharmazeutische zusammensetzungen die es enthalten.
DE68919887D1 (de) Verfahren zur Herstellung von 1-alpha,25-dihydroxy-vitamin D2 und dessen 24-Epimer.
SE8304821D0 (sv) Arabinogalaktaner, deras framstellning och kompositioner innehallande desamma
DE68908350D1 (de) Aluminiumhydroxid vom boehmit-typ, verfahren zu dessen herstellung und das hydroxid als wirksamen bestandteil enthaltendes phosphationen-adsorptionsmittel.
DE68911323D1 (de) Verfahren zur Herstellung eines Elektrokatalysators.
LU80683A1 (de) Chloracetanilide,verfahren zur herstellung dieser verbindungen sowie diese enthaltende herbizide mittel